Thursday, June 18, 2015

Gross, Gundlach, Faber Batter Bernanke as Stocks Tumble

Tough stuff from leading prognosticators in response to comments on Wednesday from Federal Reserve Chairman Ben Bernanke.

Granted, most aren’t known for their sunny optimism; but even for them it went beyond the pale. Jeffrey Gundlach doesn’t like bond alternatives; Bill Gross doesn’t like the Fed; Marc Faber doesn’t like Obama and Peter Schiff doesn’t like anybody. Judging from Wednesday’s and Thursday’s stock sell-off, they might be on to something.

The Dow Jones industrial average plunged 353 points, or 2.3%, to 14,758 points. The Dow has lost 560 points in the past two days, wiping out its gains from May and June. The Standard & Poor's 500 dropped 40 points, or 2.5%, and the Nasdaq fell 78 points, or 2.3%.

The lifeblood of America’s ailing economy—the Fed's emergency monetary infusion via quantitative easing—may be “anemic, oxygen-starved, or even leukemic,” bond king Bill Gross warned in his June missive to PIMCO shareholders. Things haven’t gotten any better since.

PIMCO co-CIO Bill GrossGross (left) told Bloomberg on Wednesday he thought Bernanke "might be driving in a fog" and said of Vice Chairman Janet Yellin, “I think she is a Siamese twin in terms of policy."

Schiff, the outspoken president of Euro Pacific Capital, was asked by the Breakout website what Bernanke could have done that would please the legendary bomb thrower.   

Peter Schiff (Photo: AP)“He could have resigned,” Schiff (right) shot back. “He’s basing his forecast of an improving economy on a housing market that was only rising because the Fed was able to blow more air back into the bubble.”

Bernanke didn’t specifically mention tapering in Wednesday’s comments because he can’t, according to Schiff.

“He knows he can’t do it. If the Fed does not start buying more than $85 billion a month of mortgages, we could have mortgage rates back above 5% by the end of this year. This whole new mini-housing boom could then be a brand new bust.”

Dr. Doom himself, Faber, editor and publisher of the aptly named "Gloom, Boom & Doom Report," recently predicted the sell-off in Japanese equities. Now he has a warning for all investors about the U.S. markets, the Fed and the rest of the world, according to Talking Numbers.

Marc Faber“[The Fed] will talk without giving any precise answers,” Faber (left) said. “I think the bond market has already weakened significantly from the July 2012 lows, in terms of yield. If the Fed indicated that it would begin tapering, equities would be more vulnerable than bonds.”

When asked about riots in emerging markets recently, and whether that made U.S. securities safe, Faber offered a glimpse of the positive before reverting to his usual pessimism.

“Yes, I would not be overly negative about U.S. bonds,” he conceded, “but it’s a more complicated question for equities.

“If someone says Mr. Bernanke has stayed to long, my view is that Mr. Obama has done the same,” Faber added with flourish.

Jeffrey Gundlach of DoubleLineAs for specific investment moves, DoubleLine Capital founder Gundlach (left) had harsh words for bond investors (recognizing he has a dog in the hunt).

"The basic viewpoint is that the financial markets, and certainly bond alternatives, are all balancing, somewhat precariously, on a very narrow base, which is zero interest rate policy,” he told CNBC. “Everybody is trying to find ways of getting yield and trying to find ways of avoiding a lousy asset class. They’re wrong, bonds are not a lousy asset class.”

The flight to bond alternatives—like dividend-paying stocks, mortgage REITs and master limited partnerships—“is going from the frying pan into the fire.”

“It’s really a fundamental mistake that investors are making,” Gundlach asserted. “They say ‘hey, I don’t want to own bonds because yields are too low, and that means that they must rise soon.’ But while bond have had modestly negative returns, these bond alternatives have had horrible returns. If the low interest rate premise is incorrect, these things will fall more than bonds.”

-----

Check out these related stories on AdvisorOne:

Wednesday, June 17, 2015

DGX to Improve Hepatitis Detection - Analyst Blog

Recently, in a bid to enhance hepatitis C virus (HCV) detection and management, Quest Diagnostics (DGX) joined forces with the US Centers for Disease Control and Prevention (CDC). Through this collaboration, the company intends to improve the public health analysis of hepatitis C screening, diagnosis as well as treatment. The process of improving Hepatitis C detection will be based on the analysis of Quest's national hepatitis C virus diagnostic information.

HCV infection is a chronic blood borne infection, which is common in the US. It acts as a major cause of liver damage and cancer. However, early diagnosis and treatment can help prevent cirrhosis, liver cancer and death.

This collaboration came on the heels of the U.S. Preventive Services Task Force's recommendation in Jun 2013, which suggested one-time hepatitis C screening for adults born between 1945 and 1965. While targeting this "baby boomer" generation, Quest noted that this age group is five times more susceptible to HCV infection than other adults. Therefore, targeting this group may prevent over 120,000 deaths.

Quest Diagnostics is optimistic about this new alliance and expects to capture a large part of the growing HCV diagnosis and treatment market in the US. At present more than 3 million people in the US are infected with hepatitis C, while many others are still unaware as to whether they are infected. Moreover, deaths from hepatitis C have doubled over the past decade to more than 15,000 a year. Thus, screening and early detection may play a vital role in curbing the fatality rate.

Currently, Quest Diagnostics has been focusing on areas with high potential such as gene-based esoteric testing for cancer, cardiovascular disease, infectious disease and neurological disorders. The company has experienced increasing demand for gene-based and esoteric tests compared to routine tests on the back of increased esoteric mix contributed by Athena and Celera. As a part of this strategy, the company completed the ! divestiture of HemoCue diagnostics products business in April.

Radiometer Medical ApS acquired the HemoCue diagnostics products business for $300 million plus customary adjustments for cash balances. Last December, the company shed its OralDNA Labs salivary-diagnostics business in order to refocus its resources on core diagnostic information services.

However, we remain cautious about Quest Diagnostics as it continues to face weak testing volume. Concerns also linger about the soft industry trends due to a decline in physician office visits, flat pricing and low organic revenues.The stock retains a Zacks Rank #4 (Sell).

While we prefer to remain bearish on Quest Diagnostics, other medical device stocks worth a look are Tornier N.V. (TRNX), Lannett Company, Inc. (LCI) andKindred Healthcare Inc. (KND). All three stocks carry a Zacks Rank #1 (Strong Buy).

Sunday, June 14, 2015

This Easy Tip Can Save You Big on Homeowners Insurance

White house in gold safeGetty Images Answer: If your deductible is $500 now, increasing it to $1,000 can lower your premiums by up to 20 percent. Most insurers offer much higher deductibles, too, which is a popular strategy for people who have enough money in emergency funds to cover potential costs. Raising your deductible is a good way to reduce your premiums, and it makes you less likely to file small claims that could result in a rate hike. At Chubb, about half of the wealthiest customers choose a deductible of $10,000 to $50,000. "For homes here in Malibu that are valued at $10 million to $25 million, having a $25,000 deductible isn't out of the ordinary at all," says Derek Ross, president of Kulchin Ross Insurance Services, an independent agency in Tarzana, Calif. The higher the deductible, the bigger the premium savings. Let's say, for example, you have a policy with Fireman's Fund with a $1,000 deductible and a $3,000 annual premium. You'd save about 24 percent by boosting your deductible to $2,500, 37 percent by raising it to $5,000, 47 percent by raising it to $10,000 and 53 percent by raising it to $25,000. Compare the premium savings with the extra dollar amount at risk to make sure that boosting your deductible is worthwhile. You should file a claim only if it is at least several hundred dollars more than the deductible. "If your insurer raises your rate by 10 percent for three to five years after you have a claim, that could easily exceed the amount the insurer paid beyond the deductible," says Ross. Whatever deductible you choose, keep enough money in an emergency fund to self-insure up to the deductible -- or even a few hundred dollars more. The risk of self-insuring may not be as high as you think. The average person files a homeowners insurance claim only once every eight to 10 years, says Jeanne Salvatore of the Insurance Information Institute. You could take the money you save in premiums and add it to your emergency fund each year so that you're prepared when you do have a claim, recommends Ross. You could also use the extra money to boost your dwelling, property and liability coverage levels by tens of thousands of dollars.

When buying homeowners insurance, be sure that you're buying enough coverage to rebuild your home, if necessary. Don't look at market prices for homes, but rather at the for your home, which would include removing what's left of your home, buying new building materials, and labor. "Guaranteed replacement" policies should cover the whole cost, while "replacement cost" coverage often covers less than the full amount. Check your policy to see what kind you have, and be sure that your home's value isn't being understated.

Wednesday, June 10, 2015

3 Canceled Shows That Could Do Wonders for Netflix Stock

Other than the occasional short squeeze, nothing drives Netflix (NASDAQ: NFLX  ) stock so much as exclusive content. But don't take my word for it. Witness what happened after House of Cards and Hemlock Grove pushed viewing hours to new highs. (More than 4 billion, according to the latest data.)

Netflix stock has more than doubled year to date and is up nearly 250% since last summer.

NFLX Total Return Price Chart

NFLX Total Return Price data by YCharts.;

If original content is at least partially responsible for the rally, then the natural question for investors is: What's next? We know Jenji Kohan's Orange Is the New Black is on the way. Other in-development projects include a second season of House of Cards and Sense8 from the Wachowskis and J. Michael Straczynski of Babylon 5 fame.

And after that? Surely there are other small projects in the works, plus a rotating schedule of exclusive content that includes a big deal with Walt Disney (NYSE: DIS  ) for rebroadcasting of the highly successful Marvel films. (The Iron Man franchise alone already accounts for $2.4 billion in worldwide box office receipts.) 

But it'll take years to get all those movies. In the meantime, resuscitating popular but recently canceled television shows could become a catalyst for Netflix stock even as Amazon.com (NASDAQ: AMZN  ) sharpens its focus on five originals: two adult comedies (i.e., Alpha House and Betas) and three kids' shows (i.e., Annebots, Creative Galaxy, and Tumbleaf).

To be clear, I'm not talking about doubling down on Arrested Development. I'm talking about newer shows with a niche following, such as The Killing. Here are three canceled shows whose earlier seasons are already available on Netflix:

Warehouse 13 
Among all the things I saw at Denver Comic-Con earlier this month, nothing surprised or delighted me so much as getting to meet Eddie McClintock, who plays Agent Pete Lattimer in this soon-to-be defunct SyFy channel show about hunting down and "bagging and tagging" powerful artifacts for storage in a mysterious warehouse located in the South Dakota wilderness. (Netflix ratings: 886,436; IMDb stars: 7.3)

Terriers 
A seedy, funny, and surprising detective series starring Donal Logue as a recovering alcoholic P.I. operating without a license and whose partner and best friend is a former thief played by Michael Raymond-James. (Netflix ratings: 115,593; IMDb stars: 8.1)

Dollhouse 
Another Joss Whedon show canceled early -- (cough) Firefly (cough) -- that starred Eliza Dushku as one of a number of programmable "dolls" for hire through their employers, a network of corporate-controlled "dollhouses." (Netflix ratings: 863,535; IMDb stars: 7.3)

Skeptics will argue that Netflix would do better developing entirely new properties. Trouble is, promoting new shows isn't cheap. Netflix spent $129 million on marketing in the first quarter alone, about even with last year's Q1. A rush of newer originals could make it harder to keep a lid on costs.  

Cult hits such as Warehouse 13 don't need the same marketing support. Think about it: McClintock and co-stars Joanne Kelly, Saul Rubinek, and Allison Scagliotti have already won over the more than 800,000 who have rated the show on Netflix. That's a powerful tailwind, one that might prove better at boosting Netflix's bottom line than would investing in an untested idea. 

Now it's your turn to weigh in. Would you have Netflix bring back any of these shows? Leave a comment to let us know what you think, and whether you would buy, sell, or short Netflix stock at current prices.

Go ahead, touch that dial
The television landscape is changing quickly, with new entrants such as Netflix and Amazon.com disrupting traditional networks. The Motley Fool's new free report "Who Will Own the Future of Television?" details the risks and opportunities in TV. Click here to read the full report!

Tuesday, June 9, 2015

Has Broadridge Financial Solutions Made You Any Real Money?

Although business headlines still tout earnings numbers, many investors have moved past net earnings as a measure of a company's economic output. That's because earnings are very often less trustworthy than cash flow, since earnings are more open to manipulation based on dubious judgment calls.

Earnings' unreliability is one of the reasons Foolish investors often flip straight past the income statement to check the cash flow statement. In general, by taking a close look at the cash moving in and out of the business, you can better understand whether the last batch of earnings brought money into the company, or merely disguised a cash gusher with a pretty headline.

Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Broadridge Financial Solutions (NYSE: BR  ) , whose recent revenue and earnings are plotted below.

Source: S&P Capital IQ. Data is current as of last fully reported fiscal quarter. Dollar values in millions. FCF = free cash flow. FY = fiscal year. TTM = trailing 12 months.

Over the past 12 months, Broadridge Financial Solutions generated $213.2 million cash while it booked net income of $160.9 million. That means it turned 9.0% of its revenue into FCF. That sounds OK.

All cash is not equal
Unfortunately, the cash flow statement isn't immune from nonsense, either. That's why it pays to take a close look at the components of cash flow from operations, to make sure that the cash flows are of high quality. What does that mean? To me, it means they need to be real and replicable in the upcoming quarters, rather than being offset by continual cash outflows that don't appear on the income statement (such as major capital expenditures).

For instance, cash flow based on cash net income and adjustments for non-cash income-statement expenses (like depreciation) is generally favorable. An increase in cash flow based on stiffing your suppliers (by increasing accounts payable for the short term) or shortchanging Uncle Sam on taxes will come back to bite investors later. The same goes for decreasing accounts receivable; this is good to see, but it's ordinary in recessionary times, and you can only increase collections so much. Finally, adding stock-based compensation expense back to cash flows is questionable when a company hands out a lot of equity to employees and uses cash in later periods to buy back those shares.

So how does the cash flow at Broadridge Financial Solutions look? Take a peek at the chart below, which flags questionable cash flow sources with a red bar.

Source: S&P Capital IQ. Data is current as of last fully reported fiscal quarter. Dollar values in millions. TTM = trailing 12 months.

When I say "questionable cash flow sources," I mean items such as changes in taxes payable, tax benefits from stock options, and asset sales, among others. That's not to say that companies booking these as sources of cash flow are weak, or are engaging in any sort of wrongdoing, or that everything that comes up questionable in my graph is automatically bad news. But whenever a company is getting more than, say, 10% of its cash from operations from these dubious sources, investors ought to make sure to refer to the filings and dig in.

With 29.5% of operating cash flow coming from questionable sources, Broadridge Financial Solutions investors should take a closer look at the underlying numbers. Within the questionable cash flow figure plotted in the TTM period above, stock-based compensation and related tax benefits provided the biggest boost, at 9.3% of cash flow from operations. Overall, the biggest drag on FCF came from capital expenditures, which consumed 16.0% of cash from operations.

A Foolish final thought
Most investors don't keep tabs on their companies' cash flow. I think that's a mistake. If you take the time to read past the headlines and crack a filing now and then, you're in a much better position to spot potential trouble early. Better yet, you'll improve your odds of finding the underappreciated home-run stocks that provide the market's best returns.

Can your portfolio provide you with enough income to last through retirement? You'll need more than Broadridge Financial Solutions. Learn how to maximize your investment income and get "The 3 DOW Stocks Dividend Investors Need." Click here for instant access to this free report.

We can help you keep tabs on your companies with My Watchlist, our free, personalized stock tracking service.

Add Broadridge Financial Solutions to My Watchlist.

Monday, June 8, 2015

What Does Wall Street See for Shanda Games's Q1?

Shanda Games (Nasdaq: GAME  ) is expected to report Q1 earnings on May 23. Here's what Wall Street wants to see:

The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Shanda Games's revenues will contract -21.7% and EPS will shrink -27.3%.

The average estimate for revenue is $172.8 million. On the bottom line, the average EPS estimate is $0.16.

Revenue details
Last quarter, Shanda Games reported revenue of $172.1 million. GAAP reported sales were 19% lower than the prior-year quarter's $215.1 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
Last quarter, non-GAAP EPS came in at $0.15. GAAP EPS of $0.12 for Q4 were 29% lower than the prior-year quarter's $0.17 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Recent performance
For the preceding quarter, gross margin was 65.4%, 390 basis points better than the prior-year quarter. Operating margin was 29.8%, 210 basis points worse than the prior-year quarter. Net margin was 19.8%, 260 basis points worse than the prior-year quarter.

Looking ahead

The full year's average estimate for revenue is $743.0 million. The average EPS estimate is $0.69.

Investor sentiment
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 300 members out of 311 rating the stock outperform, and 11 members rating it underperform. Among 38 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 31 give Shanda Games a green thumbs-up, and seven give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Shanda Games is outperform, with an average price target of $4.38.

Software and computerized services are being consumed in radically different ways, on new and increasingly mobile devices. Many old leaders will be left behind. Whether or not Shanda Games makes the coming cut, you should check out the company that Motley Fool analysts expect to lead the pack in "The Next Trillion-dollar Revolution." Click here for instant access to this free report.

Add Shanda Games to My Watchlist.

Thursday, June 4, 2015

Can AMD Finally Find Its Own Way?

On Thursday, Advanced Micro Devices (NYSE: AMD  ) will release its latest quarterly results. The key to making smart investment decisions on stocks reporting earnings is to anticipate how they'll do before they announce results, leaving you fully prepared to respond quickly to whatever inevitable surprises arise.

AMD has struggled throughout its existence, laboring in the shadow of Intel (NASDAQ: INTC  ) during the heyday of the PC and more recently falling behind many other rivals in the mobile revolution. Can the company finally get its strategy right, or is it doomed to failure in both market niches? Let's take an early look at what's been happening with AMD over the past quarter and what we're likely to see in its quarterly report.

Stats on AMD

Analyst EPS Estimate

($0.17)

Year-Ago EPS

$0.12

Revenue Estimate

$1.05 billion

Change From Year-Ago Revenue

(34%)

Earnings Beats in Past 4 Quarters

2

Source: Yahoo! Finance.

Will AMD get the chip off its shoulder this quarter?
Analysts haven't had much hope for AMD's earnings in recent months, having widened their loss estimates for the just-finished quarter by $0.01 per share. Their call for full-year 2013 has gotten worse still, with a $0.04 per share increase in expected losses. The stock has reflected similarly pessimism, dropping 9% since early January.

AMD has a long history of struggling behind Intel's dominance in the PC market. Yet even with its also-ran status in PCs, AMD remains sensitive to the conditions of the overall industry, as the stock fell alongside Intel after last week's report of plunging PC sales.

In order to survive, AMD appears to be trying its hand at certain niche markets. Last month, AMD invested in Aviary, a privately held company that makes photo-editing software. If the move gets AMD better exposure in high-potential areas like high-level digital photography and professional graphic design, then it could give it a competitive advantage over Intel and other rivals.

Yet it's unclear that the niches that AMD is targeting are big enough to keep the company moving forward. For instance, reports that Microsoft (NASDAQ: MSFT  ) will include AMD chips in its coming new upgrade to its Xbox gaming console were enough to send AMD stock soaring. Yet even with Microsoft's past success in the gaming space, it's far from clear whether a refreshed Xbox will have the same success in light of increased online gaming. Moreover, even success for Microsoft might not give AMD's revenue enough of a boost to make a lasting difference.

In AMD's quarterly report, watch for more substantial initiatives to try to penetrate the mobile market or other high-potential specialty areas. Without something to distinguish AMD from its competitors, it's hard to see the stock moving higher in the near future.

AMD knows all too well that when it comes to dominating markets, it doesn't get much better than Intel's position in the PC microprocessor arena. However, that market is maturing, and Intel finds itself in a precarious situation longer term if it doesn't find new avenues for growth. In this premium research report on Intel, our analyst runs through all of the key topics investors should understand about the chip giant. Click here now to learn more.

Click here to add AMD to My Watchlist, which can find all of our Foolish analysis on it and all your other stocks.

Wednesday, June 3, 2015

How 'Chained CPI' Will Hit Your Pocketbook

President ObamaGetty Images President Obama's new budget proposal includes changing a couple of key inflation calculations to something called a "chained CPI." The shift is getting a lot of attention right now because of the expected effect it will have on individuals. There are two key places where a chained CPI -- short for consumer price index -- will have a direct impact on your pocketbook: income taxes and Social Security benefits. All else being equal, over time, your income taxes will be higher and your Social Security benefits will be lower than they are under current inflation calculations. The key difference between the chained CPI and the traditional consumer price index is how the index measures consumer behavior. The chained CPI assumes that as prices rise on one product, some portion of consumers will be willing to substitute less expensive alternatives for what they used to buy. That changes the product weightings used in the inflation calculation. By incorporating information from those new product weightings, the chained CPI typically produces a lower inflation level. Here's how it works. The Impact on Income Taxes If you pay income taxes, your tax bracket is determined by the amount of taxable income you make. The cutoffs for each bracket generally rise over time with inflation. The two charts below show the IRS "Schedule X" brackets for single taxpayers; the first is for 2012, and the second is what's currently expected for 2013: IRS ChartChart for 2012 from the U.S. Internal Revenue Service Chart for 2013 from the US Internal Revenue ServiceChart for 2013 from the U.S. Internal Revenue Service While the 39.6 percent tax rate is new for 2013, note that the other brackets have higher cutoffs for 2013 than they did for 2012. That's thanks to the inflation adjustment made to the tax brackets. If the law is changed so that the chained CPI is used, the tops of those brackets are expected to rise more slowly, exposing more of your income to higher tax rates than under current law. The Effect on Social Security Benefits Similarly, Social Security benefits are increased based on the inflation rate. By tying the payment increases to the chained CPI -- an inflation rate that grows more slowly than the current measure -- those benefit payments will grow less quickly as well. As a result, over time your Social Security checks will be smaller than they would have been under the old inflation calculation. The annual changes aren't too extreme -- they're estimated to be somewhere in the vicinity of 0.1 percent to 0.3 percent per year, depending on what the future brings. But over time, it adds up to real money for those who pay income taxes or receive Social Security checks, with official estimates in the neighborhood of $340 billion in higher taxes and lower costs over the next 10 years. Is It Better? Is It Fair? To some extent, the chained CPI is more effective at measuring the behavior changes that we all make whenever possible to save some cash. For example, if you've switched to generic medications whenever they're available, you're doing exactly what the chained CPI expects you to do. Likewise, if you started carpooling or taking the bus in response to higher gas prices, you're changing your behavior based on higher prices, just like the chained CPI projects. On the flip side, of course, not all costs are easily switchable, especially for the seniors who rely on Social Security. For instance, health care costs have been rising faster than the overall inflation rate for decades, and older folks generally have higher health care costs than younger ones do. As a result, the change to a chained CPI will very likely make the gap between income growth and health care spending growth even more painful for seniors on Social Security. The Big Picture Still, if slowing the rate of benefit increases puts off the day of reckoning for when the Social Security Trust Fund runs out of cash and slashes benefits by around 25 percent, it may be worth it. That date is currently estimated to be a mere 20 years away -- well within the expected life span of most current workers and even some early retirees. To make it worse, if the CBO's recent release on Social Security is any indication, the next Social Security Trustees' Report may even pull that date even closer. Given a choice between a slower rate of growth or a hard slash of 25 percent at some point in the not-too-distant future, neither option seems ideal. But still, a slower rate of growth is a lot less painful than waking up one day to find your sole source of income has shrunk by a quarter of its former value.

Your age when you collect Social Security has a big impact on the amount of money you ultimately get from the program. The key age to know is your full retirement age. For people born between 1943 and 1954, full retirement age is 66. It gradually climbs toward 67 if your birthday falls between 1955 and 1959. For those born in 1960 or later, full retirement age is 67. You can collect Social Security as soon as you turn 62, but taking benefits before full retirement age results in a permanent reduction of as much as 25% of your benefit.

Monday, June 1, 2015

Benzinga Weekly Preview: U.S. Data In Focus

Related STZ Big Lots Maintains Sheen, Hits 52-Week High - Analyst Blog AB InBev Hits 52-Week High as World Cup Frenzy Rises - Analyst Blog Bulls Charge the Street as Traders Cheer FOMC Minutes (Fox Business) Related UNF Company news for April 03, 2014 - Corporate Summary #PreMarket Primer: Thursday, April 3: ECB Outcome Awaited

With Independence Day shutting US markets down for a long weekend, next week will be a slow week for earnings reports. However, an influx of economic data will more than make up for it and give investors plenty to consider. US data is expected to show that the nation’s recovery is back on track with both jobs data and PMI data forecast to impress. Fed Chair Janet Yellen is set to speak at the International Monetary Fund on Wednesday, a talk that will be closely watched as investors look for clues about the bank’s policy tightening timeline.

Key Earnings Reports

Next week, investors will be waiting for several key earnings reports including Paychex (NASDAQ: PAYX), Constellation Brands (NYSE: STZ) and Unifirst (NYSE: UNF)

Paychex Inc

Paychex is expected to report fourth quarter EPS of $0.40 on revenue of $617.35 million, compared to last year’s EPS of $0.38 on revenue of $585.30 million.

On March 28, Merrill Lynch maintained Paychex at a Neutral rating with a $47.00 price objective, noting that competition among payroll providers was high and may have an impact on the company’s growth.

“PAYX continues to face increased competition from SaaS-based payroll providers & Intuit, among others. Management noted that both its SurePayroll (SaaS offering) and full-service offerings with added online features are growing well. We expect Paychex will compete effectively but have concerns that growth in SaaS-based payroll offerings may limit pricing power for the full-service offering over time. Paychex should benefit from an improving cyclical market and greater reliance on payroll data due to healthcare reform. However, questions remain around the competitive environment. Valuation incorporates much of the improving cycle, with PAYX trading at 22x CY15E EPS, in line with its 22x 10 year median forward P/E. We maintain our $47 price objective, based on 24.5x CY15E EPS of $1.92.”

A day earlier, on March 27, Credit Suisse had a similar opinion on Paychex with a Neutral rating and a $41.00 price target. The analysts at Credit Suisse said the company’s shares are already fully valued and that there was little upside to be seen in the near future.

“Despite investments in the business via M&A, JVs, and revamping its omnichannel user experience, PAYX's profitability continues to increase. While operating margin (ex-float) guidance suggests a sequential and y-o-y contraction we view this as conservative given the ~130 bps of expansion through the first nine months. PAYX currently trades at ~24x our CY14 EPS, a considerable premium to the peer group average of 17x). With PAYX's relatively anemic growth prospects (high-single-digit EPS growth) we do not see any significant upside to the current share price.”

On June 27, Morgan Stanley maintained Paychex at an Underweight rating, noting that competition could stifle the company’s growth.

“Although PAYX has a strong recurring revenue business model, its exposure to the smaller businesses creates potential for pricing pressure and share loss to cheaper SaaS-based solutions. High total yield but increasing payout ratio indicates slowdown in growth. Growth opportunities in HR exist but we believe these are reflected in the multiple after recent runup in share price.”

S&P Capital IQ maintained Paychex at a Strong Sell rating with a $35.00 target price on June 21, saying that the stock is notably overvalued.

“We downgraded our opinion on the shares to Strong Sell from Hold in March 2014, based largely on valuation. We see lacking top-line growth, largely reflecting a tepid expansion of the U.S. economy and persistently low interest rates. While we have noted improving domestic employment data, we believe it is more than adequately reflected in the stock price. We see the stock as notably overvalued, notwithstanding a healthy balance sheet and considerable dividend.”

Constellation Brands

Constellation Brands is expected to report EPS of $0.92, compared to last year’s EPS of $0.38.

On June 23, Merrill Lynch maintained Constellation Brands at a Buy rating with a $95.00 price objective. The firm said it expects to see strong EPS growth over the next three years.

“We look for mgmt. to provide an update to the current state of the business. Key areas of focus will be 1) Progress on Crown integration and brewery expansion plans 2) Comments on US beer industry pricing, 3) Updated commentary on wine/spirits trends in the US market. Our $95 PO is based on 21.8x CY15 EPS of $4.37. This is a 15-20% premium to its  international brewer peers, which is in our view is warranted by the higher than average EPS growth (led by imported beer) we expect over the next three years.  Our trade checks and recent competitor comments and results indicate that US  beverage alcohol market is healthy into the upcoming summer season and that STZ trends in beer and wine have broadly held. Our PO reflects this dynamic as well as the potential for STZ to grow faster than its food/beverage peers in CY14.”

On June 21, S&P Capital IQ maintained Constellation Brands at a Strong Buy rating with a $98.00 price target. The analysts at S&P cited the company’s 2012 agreement with Anheuser-Busch as reason for their optimism.

“We view the shares as very attractive, trading at a discount to peers. In June 2012, STZ signed an agreement with Anheuser-Busch InBev SA/ NV (A-B InBev) to buy the remaining 50% interest in Crown Imports LLC that it does not already own for $1.85 billion. To address antitrust concerns from the Department of Justice (DOJ), A-B InBev agreed to sell STZ the rights in perpetuity to Grupo Modelo brands distributed by Crown in the U.S. and a state-of-the-art Mexican brewery for an additional cost of $2.9 billion. The acquisition closed in June 2013.”

Unifirst Corporation

Unifirst is expected to report third quarter EPS of $1.42 on revenue of $349.24 million, compared to last year’s EPS of $1.43 on revenue of $355.76 million.

S&P Capital IQ maintained UniFirst at a sell rating with a $96.00 price target on June 21. The analysts at S&P said they expect to see the company’s growth start to fizzle out this year.

“We see a wide range of customizable product and service offerings and high levels of customer service as underlying strengths in UNF's business. However, after benefiting over the last few years from large account sales, significant growth in its flame resistant garment business that was driven by oil and natural gas exploration, and higher pricing and merchandise recovery charges, we expect the company's top-line and earnings growth to moderate in FY 14. Our outlook is also tempered by continuing high unemployment levels in the U.S. and Canada, as UNF's Core Laundry segment revenue is largely driven by the number of employees at its customers.”

Economic Releases

After US data disappointed this week, a spate of new releases from America will be highly anticipated next week. The unemployment rate is expected to have remained constant at 6.3 percent while US employers likely added nearly 200,000 workers in June. PMI reports are forecast to show expansion in both the services and manufacturing sectors within the US as well.

Also on the radar will be the European Central Bank’s policy meeting, which is set for Thursday. The bank isn’t expected to make any moves as they eased considerably at June’s meeting, but the press conference following the meeting will likely shed some light on the bank’s expectations for the bloc’s economy now that the new easing package is falling into place.

Daily Schedule:

Monday

Earnings Releases Expected:  No notable releases expected Economic Releases Expected: Chinese manufacturing PMI, Japanese Tankan survey, US pending home sales, German retail sales and Japanese housing starts

Tuesday

Earnings Expected: A. Schulman (NASDAQ: SHLM), Acuity Brands (NYSE: AYI), Franklin Covey (NYSE: FC) and Paychex (NASDAQ: PAYX) Economic Releases Expected: US ISM manufacturing PMI, US redbook, British manufacturing PMI, German unemployment rate, French manufacturing PMI, Italian manufacturing PMI, Spanish manufacturing PMI and Reserve Bank of Australia interest rate decision

Wednesday

Earnings Expected: Constellation Brands (NYSE: STZ), Synnex (NYSE: SNX) and Unifirst (NYSE: UNF). Economic Releases Expected:  Chinese services PMI, US oil inventory data, eurozone PPI and British construction PMI

Thursday

Earnings Expected From: Markets Close At 1pm ET Economic Releases Expected:  US ISM non-manufacturing PMI, US unemployment rate, US trade balance, European Central Bank interest rate decision, Eurozone retail sales, British services PMI, French services PMI, German services PMI, Spanish services PMI and eurozone services PMI.

Friday

U.S. Markets Closed For July 4 Holiday

Posted-In: European Central Bank Federal ReserveAnalyst Color Earnings News Eurozone Previews Forex Global Economics Federal Reserve Pre-Market Outlook Markets Trading Ideas Best of Benzinga

© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  Most Popular Regarding Afrezza, FDA Statement: Rackspace Down 7% On Rumor It Can't Find Buyer Apple TV Vs. Android TV Vs. Fire TV Vs. PlayStation TV UPDATE: Credit Suisse Reiterates On Schlumberger Limited Following Impressive Analyst Meeting Pfizer, Bristol-Myers Squibb Announce Positive Opinion For Treatments #PreMarket Primer: Friday, June 27: U.S. Data Fuels Fed Rate Hike Debate Related Articles (AYI + FC) Benzinga Weekly Preview: U.S. Data In Focus Top 4 Mid-Cap Stocks In The Diversified Electronics Industry With The Highest EPS Around the Web, We're Loving...

Sunday, May 31, 2015

Up 31%: Why Pernix Therapeutics Surprised Investors

Shares of Pernix Therapeutics  (NASDAQ: PTX  ) soared 31% yesterday after the company revealed that it had bought the U.S. rights to GlaxoSmithKline's (NYSE: GSK  ) Treximet (which helps treat migraines in adults) for $250 million upfront (and some potential additional payments later). The importance of this purchase cannot easily be overstate for Pernix -- the company had $85 million in revenue last year, while Treximet on its own brought in $79 million -- and Pernix clearly sees some additional upside potential for the drug, whether it's through a potential indication expansion (to pediatric patients) or through synergies with Pernix's current salesforce.

Where could Pernix unlock additional value for the drug? In the video below, Motley Fool health care analysts Michael Douglass and David Williamson discuss Pernix's plans for the drug and how this deal jives with the company's current offerings.

Even with today's pop, can Pernix keep up with this top stock?
Great stocks don't just have a great day -- we're looking for a great long-term investment. And every year, The Motley Fool's chief investment officer hand-picks 1 stock with outstanding potential. But it's not just any run-of-the-mill company. It's a stock perfectly positioned to cash in on one of the upcoming year's most lucrative trends. Last year his pick skyrocketed 134%. And previous top picks have gained upwards of 908%, 1,252% and 1,303% over the subsequent years! Believe me, you don't want to miss what could be his biggest winner yet! Just click here to download your free copy of "The Motley Fool's Top Stock for 2014" today.

Thursday, May 28, 2015

Ketchum’s WSJ Comments on SRO Defeat Aren’t the Final Words, Watchers Say

Comments made by Richard Ketchum, CEO of the Financial Industry Regulatory Authority, to The Wall Street Journal Thursday that FINRA has “done the Sisyphus climb” to be given authority over investment advisors, and that FINRA doesn’t “perceive any likelihood that [such SRO attempts] would be successful” seemed to signal a new declaration of defeat by Ketchum.

But industry officials opine that Ketchum was merely addressing the lack of support in the current Congress for FINRA to become the self-regulatory organization for advisors, and that FINRA will indeed assess Congress’ appetite for such support in future legislative sessions.

Industry watchers keyed on Ketchum’s comment in the WSJ article that FINRA isn’t pursuing being the SRO for advisors “at the present time.”

“I think most folks watching this [SRO] issue would say it’s dead in this Congress,” says Duane Thompson, senior policy analyst at fi360. “Ketchum’s qualifying statement, ‘at the present time,’ suggests that the time may not be ripe for an SRO bill to advance this year in Congress, but that in future legislative sessions FINRA will continue to closely monitor the mood of Congress and its appetite for a new advisor SRO.”

Neil Simon, vice president for government relations at the Investment Adviser Association, agrees. “By stating that FINRA is not pursuing efforts to gain authority over advisors ‘at the present time,’ it is evident that FINRA has not abandoned its long-sought goal of extending its regulatory reach to advisors.”

Although FINRA may not be “actively lobbying on Capitol Hill right now,” Simon adds, the self regulator “is in for the long haul and it’s only a matter of time before they’ll be back.”

Ketchum told the Journal that Congress should provide the SEC with the resources necessary to boost advisor exams. The SEC has said it now can examine investment advisory firms once every 10 years on average. Ketchum told the Journal that scant oversight "creates issues from the standpoint of everything from classic Ponzi schemes to abuse."

Chris Paulitz, senior vice president of membership and marketing at the Financial Services Institute, adds that “as we have said for two years, Rick is right, and there is no political consensus on how to allocate greater resources towards increased investment advisor examinations.”

SEC Chairwoman Mary Jo White said in late March that there was “a crying need” for more resources to help the agency boost its examination of the nation’s investment advisors, and the agency has asked Congress for more money to do so.

This Relative Strength Play Is Ready to Explode

DELAFIELD, Wis. (Stockpickr) -- Lots of people freak out whenever markets are dropping like they are right now -- but not me. I get ridiculously excited!

>>5 Hated Earnings Stocks You Should Love

The reason I get excited when markets are getting hit hard by the bears is that when your trading screens are a sea of red, it's very easy to identify strong names that aren't being hit in the overall market weakness. These strong names are displaying relative strength, which is simply a measure of how strong a stock is compared with the overall market. The thinking here is that if the bears can't take a stock down when they're in full control of the markets, then that stock has potentially exhausted its sellers and the buyers are in control.

Wall Street has conditioned traders and investors to buy stocks that are going down during big market corrections. That strategy is not a wise one, unless the stock has found a bottom and has finished its downtrend. If you buy a stock that's displaying relative weakness in market drops, then you're going to get caught trying to catch a falling knife. A better way to approach market corrections is look for the stocks that aren't going down and are displaying relative strength. These names are often setting up to be the next big movers and for good reason: They have buyers.

>>3 Huge Stocks on Traders' Radars

A perfect example of this can be seen in the performance of Agios Pharmaceuticals (AGIO) today, which is soaring higher by 24% to over $44 a share. On Friday, as the market was hammered lower, shares of AGIO actually closed higher at $35.48, back above the stock's 50-day moving average of $35.03 and well above its intraday low of $31.42 a share. Now, to be fair, AGIO had big news today after the company reported that its blood cancer drug, AG-221, showed promising clinical activity. That said, it still wasn't going down on Friday, which was a signal that the stock had real buyers.

Other stocks hitting my scans that aren't going down on this solidly red day include American Apparel (APP), Acorda Therapeutics (ACOR), Sarepta Therapeutics (SRPT), Questcor Pharmaceuticals (QCOR) and J.C. Penney (JCP). All of these stocks are displaying relative strength intraday, so traders should now keep a close eye on how they close to see if the bulls remain in charge.

One stock that's really jumping out at me here that's displaying relative strength during this market weakness is Rocket Fuel (FUEL), a technology company that provides artificial-intelligence digital advertising solutions. Shares of FUEL are up about 1.7% on the day with volume that's tracking in pretty strong, since over 580,000 shares have traded vs. its three-month average volume of 683,332 shares.


Part of the reason that Rocket Fuel is moving higher today is due to the fact that BMO Capital upgraded the stock to outperform from market perform based on valuation. The firm said its price target of $58 a share will remain. That being said, I love this upgrade for a much better reason, which is the fact that shares of FUEL might be putting in a bottom here from a technical perspective.

If you take a glance at the chart for FUEL, you'll notice that this stock has been absolutely crushed over the last two months and change, with shares plunging lower from its high of $71.24 to its recent low of $38.12 a share. During that crash, shares of FUEL have been mostly making lower highs and lower lows, which is bearish technical price action. To put that drop into perspective, shares of FUEL have plunged over 30% over the last three months. That's a serious drop and anyone who has held the stock through that decline is in some serious pain.

One group that is very happy with the recent performance for FUEL is the short-sellers. The current short interest as a percentage of the float for FUEL is extremely high at 24.4%. That means that out of the 13.53 million shares in the tradable float, 3.31 million shares are sold short by the bears. This is a huge short interest on a stock with very low float.

>>5 Rocket Stocks Ready for Blastoff

I am normally not a big fan of brokerage upgrades or downgrades, but I like this call by BMO Capital for one major reason: the developing technical setup for FUEL. Shares of FUEL are potentially putting in a double bottom here at $37.81 to $38.12 a share. That $37.81 level is from last November and that $38.12 level is the intraday low the stock hit on Friday. If these levels hold as major support, then shares of FUEL could be an absolutely steal at current prices for the longer-term and a great trading play in the short-term.

Traders should now look for long-biased trades in FUEL as long as its trending above those double bottom support zones at $38.12 to $37.81 a share and then once it breaks out above some near-term overhead resistance levels at $42.50 to $45 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average action of 683,332 shares. If that breakout triggers soon, then FUEL could easily bounce sharply higher and tag its 50-day moving average of $51.07 a share to even $55 a share.

Considering the low float and higher short interest combined with the potential double bottom for shares of FUEL, the bears might want to really consider covering their positions unless they can break the stock back below those double bottom support levels. If the bears can break the stock below the double bottom levels with volume, then all bets are off the bulls. However, a large short-squeeze rebound trade looks more likely to me considering how oversold the stock is and the fact it's displaying some relative strength today.

-- Written by Roberto Pedone in Delafield, Wis.


RELATED LINKS:



>>5 Stocks Poised for Breakouts



>>5 Toxic Stocks to Sell Now



>>Sell This Momentum Stocks Before It's Too Late

Follow Stockpickr on Twitter and become a fan on Facebook.

At the time of publication, author had no positions in stocks mentioned.

Roberto Pedone, based out of Delafield, Wis., is an independent trader who focuses on technical analysis for small- and large-cap stocks, options, futures, commodities and currencies. Roberto studied international business at the Milwaukee School of Engineering, and he spent a year overseas studying business in Lubeck, Germany. His work has appeared on financial outlets including

CNBC.com and Forbes.com. You can follow Pedone on Twitter at www.twitter.com/zerosum24 or @zerosum24.


Monday, May 25, 2015

Apple drops top Bitcoin app from marketplace

blockchain

Apple has yanked Blockchain, a digital wallet app for bitcoins, out of its mobile marketplace without explanation.

NEW YORK (CNNMoney) Apple has pulled popular Bitcoin app Blockchain out of its mobile marketplace without explanation.

The Blockchain app, downloaded 120,000 times during its two years in Apple's iTunes App Store, was the most popular way for people and companies to transfer bitcoins from one another. Apple removed it from the store on Wednesday.

Blockchain immediately shot back with a statement, accusing Apple (AAPL, Fortune 500) of getting overly aggressive with future competitors. Apple is rumored to be developing its own mobile payment system.

"These actions by Apple once again demonstrate the anti-competitive and capricious nature of the App Store policies that are clearly focused on preserving Apple's monopoly on payments rather than based on any consideration of the needs and desires of their users," a spokesman for Blockchain said.

Buy this $8M mansion with bitcoins   Buy this $8M mansion with bitcoins

In its email alerting Blockchain of its decision, Apple referenced an "unresolved issue." But Apple didn't expand on that, and the company did not respond to a request for comment.

Bitcoin users are calling Apple a bully. Many are threatening to ditch iPhones and iPads for devices that run Google's Android. Blockchain is still available in the Google (GOOG, Fortune 500) Play Store.

"It is as if IBM (IBM, Fortune 500) would have banned email clients in the early 90's," said Michael Kondratov, president of the Aspire Auctions in Cleveland and Pittsburgh. Kondratov recently started allowing customers to bid on antiques and art using bitcoins.

"I feel Apple is no longer a 'rebel' company," he wrote in an email.

Related story: Zynga testing Bitcoin payments for games

Elizabeth Ploshay, a board member with the advocacy-focused Bitcoin Foundation, called it "truly upsetting" that Apple has distanced itself from the growing Bitcoin-using business community.

Blockchain's CEO, Nick Cary, noted that the company spent more than $100,000 developing the app. He said software developers are already working on making an HTML5 version that will work through all Internet browsers, including Apple's ! Safari. That would essentially render Apple's stand fruitless.

"They're on the wrong side of technology and history here," Cary said.

Apple hasn't yanked every Bitcoin-related app, though. Dozens still exist in its mobile marketplace as of Thursday morning.

The company's move is the latest event putting pressure on Bitcoin, which has grown in popularity because of its independence from government-controlled currencies. But Bitcoin maintains a stigma due to its frequent use in online drug markets like Silk Road.

Last week, U.S. law enforcement agents arrested the CEO of Bitcoin exchange BitInstant and charged him with laundering money for Silk Road customers. Additionally, lawmakers have called for increased regulation of Bitcoin in light of the currency's heightened privacy. Bitcoins can be traded without using names and are difficult to trace to individuals.

But bitcoins aren't just for drug dealers. Many legitimate businesses -- everything from Subway sandwich shops to barbers -- have adopted the digital currency. To top of page

Sunday, May 24, 2015

One Month & Counting ‘Til Tax Time: IRS

The Internal Revenue Service has good news for taxpayers: The opening day for the 2014 filing season is Jan. 31, 10 days later than it first planned and one day later than a year ago.

(Deductions for charitable donations and other purposes to be included on 2013 tax returns, however, must be made by Dec. 31.)

In the wake of IT issues with Affordable Health Care Act, the IRS says it wants to have “adequate time to program and test its tax processing systems.” The federal agency, which relies on more than 50 systems to process about 150 million tax returns each year, says that its testing schedule was pushed back this fall due to the 16-day federal government closure.

“Our teams have been working hard throughout the fall to prepare for the upcoming tax season,” IRS Acting Commissioner Danny Werfel said in a press release. “The late January opening gives us enough time to get things right with our programming, testing and systems validation. It’s a complex process, and our bottom-line goal is to provide a smooth filing and refund process for the nation’s taxpayers.”

As in prior years, the IRS is asking taxpayers to use e-file or Free File as the quickest way to receive refunds.

The IRS recommends that taxpayers review the latest year-end tax planning information that’s now up on its website.

One document that’s full of details on tax-saving opportunities is Publication 17. The 292-page guide explains the American Opportunity Tax Credit for parents and college students, as well as the Child Tax Credit and Earned Income Tax Credit for low- and moderate-income workers.

Some of the tax changes for 2013 to keep in mind include:

The IRS says some software firms should begin accepting tax returns in January. They will hold those returns until the IRS systems open on Jan. 31.

 

 

Wednesday, May 20, 2015

Target Reports 40 Million Credit, Debit Cards May Have Been Hacked

By Hal M. Bundrick

NEW YORK (MainStreet) Your holiday shopping may have just taken an ugly turn. If you shopped at a Target store between November 27 and December 15 and used a debit or credit card, keep a close eye on your bank account. There's a good chance you've been hacked. Some 40 million cards accounts may be affected by an expansive security breach, according to a Target statement. The company has retained the services of a third-party forensics firm to assist in the investigation.

"Target's first priority is preserving the trust of our guests and we have moved swiftly to address this issue, so guests can shop with confidence. We regret any inconvenience this may cause," said Gregg Steinhafel, chairman, president and CEO of Target. "We take this matter very seriously and are working with law enforcement to bring those responsible to justice."

The popular national chain says the "issue has been identified and resolved." Unauthorized access to Target payment data potentially impacts purchases made at all of the 1,797 Target stores in the U.S. during the two and a half week period. "We began investigating the incident as soon as we learned of it," a statement on the Target Website says. "We have determined that the information involved in this incident included customer name, credit or debit card number, and the card's expiration date and CVV (the three-digit security code)." Consumers are urged by the company to keep a close eye on their accounts for signs of fraud or identity theft. Any suspicious or unusual activity should be reported to the financial institution that issued the credit or debit card. --Written by Hal M. Bundrick for MainStreet

Tuesday, May 19, 2015

LinkedIn's Earnings: What Investors Need to Know

Social-media job recruiter, LinkedIn (NYSE: LNKD  ) is reporting results later today. While the Street is still sifting through Apple's earnings report and eagerly awaiting results from LinkedIn's social-media brethren, Facebook  (NASDAQ: FB  ) , could investors be overlooking an opportunity with LinkedIn? What should LinkedIn investors know, and what can LinkedIn learn from Facebook?

Amazing revenue growth must continue
S&P's Capital IQ consensus estimates project LinkedIn to report revenue of $385.5 million, an amazing 53% higher than last year's quarter. Revenue growth is extremely important and will be watched closely; investors have been extremely bullish on LinkedIn's prospects and have bid the company up from a price-to-sales ratio of 12 to its current ratio of nearly 23. If LinkedIn doesn't hit this ambitious goal, it's possible we could see a large selloff.

Guidance is important too
In addition to reporting phenomenal revenue for this quarter, LinkedIn must provide positive guidance for next quarter and the upcoming year. While the current consensus revenue estimate is receiving the most attention, lost is the fact that analysts are expecting LinkedIn to increase this quarter's revenue by over 40% in the September 2014 quarter by reporting $544.8 million.

Here's why they will do both
In a nutshell, the answer is mobile: LinkedIn has an aggressive plan to build out its mobile network, even hosting its first Mobile Day on Oct. 23. CEO Jeff Weiner hailed mobile as a "game-changer" for LinkedIn's products and revenue.

Looking at the numbers one can understand why: Mobile users are 2.5 times as active as desktop-only users. And while LinkedIn is more than just a social-media advertising model (54% of its revenue is talent solutions—job postings—and another 20% is premium subscriptions), all three of its business divisions will benefit from a more engaged user base.

LinkedIn is aggressively attacking this new opportunity. In addition to the company redesigning its iPad app, it also announced Intro to attaches profile information about an email's sender. While there were grumblings about privacy and security, you can see how LinkedIn is aggressively targeting the mobile experience.

Why the sudden change of heart?
Many initially thought that LinkedIn should have continued to build its website around the desktop experience and wonder why LinkedIn decided to pivot to mobile. The answer? To paraphrase famous bank robber Willie Sutton, "because that's where the monetization is."

Facebook shocked investors by growing mobile revenue from nearly nothing to 41% of its total ad revenue in the company's second quarter. Mark Zuckerberg even stated in his call that he expected to have more revenue on mobile than on desktop. Facebook reports tomorrow, and many investors expect the monetization in mobile to continue.

Final Foolish thoughts
LinkedIn is a clear leader in this space and has become a must have for any career-oriented professional. Wall Street has high hopes for revenue growth, guidance, and monetization of mobile. LinkedIn has ambitious targets but appears to have a plan to meet those goals.

Social media investors need to watch this video
LinkedIn is a fantastic story, so much so that we can't cover it all in a single article. Find out what I can't say in this special video. LinkedIn is growing twice as fast as Google and Facebook, and more than three times as fast as Amazon.com and Apple. Watch our jaw-dropping investor alert video today to find out why The Motley Fool's chief technology officer is putting $117,238 of his own money on the table, and why he's so confident this will be a huge winner in 2013 and beyond. Just click here to watch!

Wednesday, May 13, 2015

Oracle Corporation (ORCL): Is Larry Ellison Being Overpaid?

The team of Larry Ellison, the founder and Chief Executive of Oracle Corporation (NASDAQ:ORCL), may have won the thirty-fourth America's Cup. However, it could be difficult for Ellison's corporate team to escape the discontent from shareholders, who are against higher pay packages for Oracle executives amid mixed results.

The shareholder angst comes as Oracle has reduced the compensation of all the key executives including Ellison who even turned down a bonus of $1.2 million for the past year as Oracle's growth missed expectations

The key reason for the shareholder displeasure stems from the stock option awards. They argue that Ellison, who beneficially owns a quarter of the company's shares, continues to receive tens of millions of dollars of stock options every year, despite Oracle's mixed financial performance. They could show their discontent at the business software maker's Oct. 31 annual meeting.

Oracle's first quarter profit rose 8 percent to $2.19 billion, or 53 cents ex-items and trumped analysts' estimates, but adjusted revenue of $8.38 billion fell short of expectations of $8.48 billion.

The CEOs of America benefit from exercised stock options and vested stock awards that normally account for more than 50 percent of executive pay. Those components of compensation are the reason these CEOs are on the list of highest-paid.

For the fiscal year that ended in May, Ellison got a compensation of $79.6 million, which includes a base salary of $1, bonus of $1,126 and stock options worth $76.9 million. The compensation represents a drop of 21 percent from $96.1 million he received last year. Despite the drop, Ellison is still one of the highest-paid CEOs in the U.S.

Safra Catz, President and Chief Financial Officer, received $44.3 million as compensation, a 17 percent decrease from $51.7 million last year. The package includes basic salary of $950 thousand, option awards worth $42.6 million and bonus of $717.2 thousand.

Even in 2012, Oracle suffered a defea! t over executive pay practices in 2012 and managed only a narrow win in 2011 despite Elliot's huge stake. Opponents included BlackRock Inc. and Vanguard Group Inc. Fifty-nine percent of shareholders rejected the company's pay practices at the last annual meeting in November.

The Compensation Committee and the rest of the Board were disappointed with the results of the fiscal 2012 Say-on-Pay vote. The company said the Compensation Committee believes Oracle's executive compensation philosophy and program achieve this goal in a manner that is appropriate for Oracle (and not necessarily other companies) and that significant changes to its executive compensation program were not warranted.

"The Compensation Committee realizes that certain of our stockholders may disagree with this conclusion, but the Compensation Committee believes that our executive compensation philosophy and the current structure of our executive compensation program are in the best interests of Oracle and its stockholders, and that, in the Compensation Committee's opinion, this belief has been validated by Oracle's historical financial and stock price performance over the long term," Oracle said in a recent regulatory filing.

This year investors could step up the pressure. CtW Investment Group, which works with pension funds sponsored by unions affiliated with Change to Win, is said to oppose Oracle's pay practices. CtW, which represents nearly 5.5 million members participate in Taft-Hartley plans with over $200 billion in assets, owns more than 5 million shares in Oracle via its pension funds.

The Wall Street Journal reported that CtW Investment Group, in a letter sent to Bruce Chizen, chairman of the Oracle board's compensation committee, said it would vote against the company's compensation practices and possibly seek to remove directors on the compensation committee if Oracle doesn't put caps on its options awards.

Interestingly, the CtW letter came the same day when Ellison was basking in the glory of h! is Americ! a Cup team's win. Investors and consumers alike were disappointed over the fact Ellison skipped his own keynote address at Tuesday's Oracle's annual conference for customers to cheer for Oracle Team USA.

CtW is a frequent critic of what it sees as excessive CEO pay, and its recent opposition to McKesson's (NYSE:MCK) executive pay practices is a proof of this. This time, CtW could get the support of mutual funds and institutional investors against Oracle.

A major drive by activists over Oracle's executive-pay levels will get considerable support from institutional investors this fall, the Wall Street Journal reported citing an official of one large mainstream money manager.

So, Oracle and Larry Ellison has a tough ask in front of them in getting approval for its pay practices at its annual meeting.

Tuesday, May 12, 2015

Batista’s OGX Faces Ibovespa Removal as Short-Sale Limit Raised

OGX Petroleo & Gas Participacoes SA, the oil company founded by Eike Batista that has dropped the most on the Ibovespa this year, faces removal from Brazil's benchmark index and the prospect of more bets against the stock.

BM&FBovespa SA (BVMF3) will exclude from the gauge any companies whose shares trade for less than 1 real (44 cents), the exchange operator said in a statement yesterday. The limit on equity lending for OGX, which has plunged 91 percent this year to 38 centavos in Sao Paulo, was raised to 50 percent of shares available for trading from 45 percent, the bourse said in a separate statement. Stock loans, used in short sales, climbed to 44.9 percent on Sept. 11, data compiled by Bloomberg show.

OGX's relative importance in the gauge has grown because of the index's reliance on trading volume for determining equity weightings. While the oil producer is the index's third-smallest company by market value, it has the third-biggest weighting of 73 Ibovespa stocks. OGX has been responsible for about half of the measure's 12 percent drop this year through yesterday as trading in the stock rose to all-time highs.

Market Cap

In addition to excluding penny stocks, the new methodology will determine company weights on the gauge by the free-float market value, adjusted for liquidity. Positions will be limited to 20 percent of the index, the bourse said.

"Using market capitalization and liquidity to calculate each stock's weighting on the gauge will make it easier for investors to replicate the index and will avert distortions," Eduardo Guardia, BM&FBovespa's investor relations director, told reporters today in Sao Paulo. "The new methodology provides a better representation of the companies that are present on the Brazilian stock market."

The index changes will be implemented in two steps starting in January 2014, and will be fully effective by May, BM&FBovespa said. The exclusion of penny stocks will be effective in January, according to Guardia.

While OGX, the most volatile stock in the 823-member MSCI Emerging Markets Index, was considered in the overhaul of Brazil's main stock gauge, the process was started before the stock's plunge overwhelmed the Ibovespa, according to BM&FBovespa's Chief Executive Officer Edemir Pinto.

Pre-Operational

Batista, whose $34.5 billion fortune in early 2012 made him the world's eighth-richest person, ceased to be a billionaire in July, according to the Bloomberg Billionaires index. All six companies that Batista listed since 2006, which have dropped as much as 93 percent this year, came to the market in pre-operational stages.

"Pre-operational projects represent an opportunity, but investors will be more cautious about these companies now," Pinto said today.

A committee of exchange executives, banks and brokerages developed the changes to the benchmark index. BM&FBovespa said on its website that it hadn't made changes to the gauge's methodology since its inception in 1968. LLX Logistica SA (LLXL3), the shipping unit that Batista founded, is the second-lowest priced stock on the Ibovespa after dropping 36 percent this year to 1.53 reais.

Sunday, May 10, 2015

Pacific WebWorks, Inc. Business Update (OTCBB:PWEB, OTCMKTS:CLNO)

pweb

Pacific WebWorks, Inc. (PWEB)

Today, PWEB remains (0.00%) +0.000 at $.0231 with 1,000 shares in play thus far (ref. google finance Delayed: 9:30AM EDT July 16, 2013).

Pacific WebWorks, Inc. previously reported the following business update. For the first six months of 2013 the Company has focused on revitalizing its internet technology business model. As previously reported, Pacific WebWorks has expanded its software suite and established a framework for reaching new markets with its software products. The Company believes there is strong demand for its products and is aggressively pursuing the opportunity to obtain new customers through a variety of marketing methods.

Lance Bell, CEO, stated, "We are excited to report a number of accomplishments during the first six months of 2013. We have rounded out our management team, finalized our infrastructure and have begun to market our software products. We are encouraged by the initial results of these efforts."

Pacific WebWorks, Inc. (PWEB) 5 day chart:

pwebchart

clno

Cleantech Transit, Inc. (CLNO)

Cleantech Transit, Inc. (OTCMKTS:CLNO) (www.cleantechtransit.net ) through its Discovery Carbon subsidiary, develops emissions offset strategies for companies, municipalities, and countries. Today, CLNO has surged (+18.00%) down +0.022 at $.147 with 95,318 shares in play thus far (ref. google finance Delayed: 11:26AM EDT July 16, 2013), but don't let this get you down.

CLNO's daily range is at ($.1475 – $.12) thus far and currently at $.147 would be considered a (+13263.63%) gain above the 52 wk low of $.0011. The stock is up +7275% since the concerning dates of January 17, 2013 – July 16, 2013. +7275% is the 6 month high and rightly so.

Cleantech Transit, Inc. (CLNO ) 5 day chart:

clnochart

Wednesday, April 29, 2015

Lawmakers Challenge Hedge Fund Ad Rules

Two lawmakers are warning Securities and Exchange Commission Chairwoman Mary Jo White that the agency must withdraw several amendments governing the newly allowed hedge fund ads or run afoul of the law.

Rep. Scott Garrett, R-N.J.In a July 22 letter to SEC Chairwoman Mary Jo White, Rep. Patrick McHenry, R-N.C., chairman of the Financial Services Subcommittee on Oversight and Investigations, and Rep. Scott Garrett, R-N.J., chairman of the Financial Services Subcommittee on Capital Markets, take issue with Proposed Rule 503, which they say “requires private issuers to file a wildly expanded Form D 15 days before” they start advertising.

"Congress did not say that the commission can delay free speech for 15 days," they wrote.

The lawmakers state that although they support the rule lifting the ban on hedge fund advertising, they request in their letter that the SEC withdraw Proposed Rule 503 “in order to uphold the intent of the law.”

Congress "specifically required the commission lift the ban on general solicitation for those Rule 506 offerings that solely target accredited investors and qualified institutional buyers," they wrote, arguing that the waiting period is in effect a ban, and that completing the paperwork requires "hiring qualified counsel" and can stretch the wait far longer than 15 days.

They called the pre-filing requirement "yet another unnecessary burden that prevents small businesses from accessing capital that they need to grow and create jobs.”

Garrett said in the letter that the SEC’s “proposed amendments to Form D filings — over the objections of two commissioners — are not called for under Section 201 of the JOBS Act.”

But A. Heath Abshure, president of the North American Securities Administrators Association President and Arkansas Securities Commissioner, says that McHenry and Garrett "fail to appreciate the need to balance the needs of business with the needs of investors" by asking the SEC to withdraw proposed Rule 503. "Such a failure would result in an unregulated ‘wild west’ market in which their constituents will lose money. Ultimately, their constituents will lose confidence in these new markets, stop investing, and look to Reps. McHenry and Garrett for answers. We encourage the SEC to resist this shortsighted political pressure and  move as expeditiously as possible to adopt the proposed investor protection amendments to Regulation D and Form D."

The lawmakers also took issue with the requirement under proposed Rule 510T to file all ads with the SEC for the first two years the rule is in effect. "Samples of data should clearly suffice" for market evaluation, they said, adding that for compliance purposes, the commission could gather the ads itself since they will be public.

They also criticized the mandate of "canned" disclosures on ads under Proposed Rule 509, saying that "in this modern Internet age ... investors generally ignore standard disclosures, either because of their overuse or limited utility."

These amendments, they wrote, “would likely increase regulatory burdens on small businesses seeking to conduct Regulation D offerings and thereby undermine the fundamental goals of the JOBS Act.”

---

Check out Surprise! Not Every Hedgie Loves the Lifted Ad Ban on ThinkAdvisor.

Tuesday, April 28, 2015

7 personal finance lessons to learn from Katrina Kaif

Inspirations come in all shapes and sizes. You would surely agree that Katrina Kaif as an inspiration is not only shapely but also quite beautiful.

Katrina was a total novice when she entered the Hindi film industry. She had no knowledge of films. Worse � she couldn�t even speak the Hindi language properly. Yet within a short span of 5-7 years she has become one of the most successful actresses in the Hindi film industry.

Many amongst you too would have no knowledge of the personal finance industry. Worse � you wouldn�t even understand the financial language. But if you are willing to work hard like Katrina, there is no reason why you too can�t become a successful manager of your money.

Lesson 1: Background and past do not matter; what matters is what you do with your present.

Her first movie was called Boom, which ironically went totally bust (even though it also starred the legendary superstar Mr. Amitabh Bachchan). But she didn�t let the super-flop discourage her. Instead of feeling sad or sorry about it, she turned the failure into a lesson. You too will experience many failures when you start investing. But don�t let them deter you. No one can be 100% successful. All you have to aim for is to have more wins than losses.

Lesson 2: Don�t be discouraged by failures, instead learn from them.

To guide her during the initial years, she found herself a mentor. He acted as her friend, philosopher and guide � educating her about the nuances of the films and film industry. More importantly, she was a willing student who worked very hard to absorb all the lessons. You too should find yourself a financial advisor who will pass on all the knowledge to you. More importantly, you should be a willing student. After all, you have to score your own goals. A coach cannot do it for you.

Lesson 3: Find yourself a mentor and be willing to learn.

The first few years of her career she worked with established and successful stars only. You too should begin your investments with large and established companies/mutual funds. There is no point in taking risks until you understand the game.

Lesson 4: To start with, invest only in top-rated and successful companies/mutual funds.

She found a certain comfort level with Akshay Kumar and gave many hits working with him. She didn�t try to experiment too much or work with many stars. Identify a few investment options that you easily understand and are comfortable with. Don�t buy too many different financial products in the initial years of your investment.

Lesson 5: Stick with a few simple investment products in the early years.

It was only when she started understanding the Hindi film industry and achieved reasonable success that she moved to younger upcoming stars such as Ranbir Kapoor, Imran Khan and Ali Zafar. She also took to doing items songs. Had she done item songs in early part of her career she would have remained an item-girl only. Only when you get a hang of the personal finance industry and have made some successful investments, should you consider investing in different products and upcoming companies. If you start with Futures/Options you will never become a successful investor.

Lesson 6: Move to riskier and specialized products only after you become a reasonably successful investor.

It would be wrong to attribute Katrina�s success to only her face and contacts. Starlets with prettier faces and better connections didn�t shine long enough. You won�t even remember their names. Ultimately, it is her attitude and dedication towards her work that has given Katrina all the success, fame and money. Likewise, the likelihood of you too becoming a multi-millionaire would be determined by just how good you are at managing the resources you have.

Lesson 7: Only �attitude� matters; rest is just a matter of details.

Professions may differ, but the underlying rules to success remain the same. Pick up any person you admire � Sachin Tendulkar, A.R. Rahman, Narayana Murthy, Kiran Bedi, Sonia Gandhi, etc. � and make him/her your inspiration. Success is waiting for you. Are you ready to grab it?

Sanjay Matai is a personal finance advisor ( http://www.wealtharchitects.in/ ) and author. � Millionaires don�t eat cakes�they make them � is his latest publication.

Cytokinetics' Update on Study - Analyst Blog

Cytokinetics, Incorporated (CYTK) recently provided an update on BENEFIT-ALS (Blinded Evaluation of Neuromuscular Effects and Functional Improvement with Tirasemtiv in ALS), the phase IIb study being conducted on its amyotrophic lateral sclerosis (ALS) candidate, tirasemtiv.

The company reported a programming error in the multinational, double-blind, randomized, placebo-controlled study which is evaluating the safety, tolerability and efficacy of tirasemtiv.

Cytokinetics' data management vendor reported that due to a programming error in the electronic data capture system controlling study drug assignment, 58 patients received placebo at a certain study visit instead of tirasemtiv.

The company said that no incorrect treatment was conducted on the patients in the placebo arm. Cytokinetics said that the company as well as trial site personnel remained blinded to the 58 patients affected by the error.

Cytokinetics is taking measures to confirm that no other such errors have been made and the programming defect has been corrected. Cytokinetics also conducted an ad hoc meeting of the study`s Data Safety Monitoring Board (DSMB) to determine that the safety of the 58 patients affected by the error has not been impacted. The DSMB reviewed the safety data and reported that there were no concerns regarding patient safety.

Patient enrolment for the BENEFIT-ALS study is ongoing – the study, which is designed to enroll up to 500 patients, has enrolled 450 patients so far. Cytokinetics said that it may change the current protocol so as to enroll additional patients.

The company is working with regulatory authorities on the most suitable way to respond to the error so that the intended scientific value of BENEFIT-ALS may be maintained.

Our Take

We do not expect the programming error to have a major impact as the study remains blinded and the error was detected well before final analysis. Moreover, the safety profile was not impacted.

Still, we ! believe the company will most likely amend the protocol and enroll additional patients. On its first quarter 2013 conference call, the company had said that results from the BENEFIT-ALS study would be out by year end. However, enrolment of additional patients could push out study results by a few months to early 2014. Study costs will also go up.

An update on the company's plans should be available following discussions with regulatory authorities.

Cytokinetics currently carries a Zacks Rank #2 (Buy). We expect investor focus to remain on results from the ATOMIC-HF study that is evaluating omecamtiv mecarbil in patients with left ventricular systolic dysfunction who are hospitalized with acute heart failure. The company intends to present results in late August-early September.

At present, companies that look well-positioned include Biogen Idec (BIIB), Peregrine Pharmaceuticals, Inc. (PPHM) and Cytori Therapeutics, Inc. (CYTX). All three are Zacks Rank #1 (Strong Buy).

Monday, April 20, 2015

Trend Channel Bounce Trades

These stocks are in strong upward trend channels, but are currently trading near the lower support line. If the channel holds, there is potential for "trend channel bounce trades," as the price rallies off support and heads back toward the top of the channel. Typically these trades are low risk, since the entry point is near the support line and stop-loss price.

Baxter International (NYSE:BAX) has been moving higher within a well defined trend channel since the start of the year. The lower channel line currently intersects near $68.75, although it looks like the stock may already be heading higher before reaching that level. On August 2 Baxter made an intra-day low of $69.31, before reversing course and closing August 6 at $72.03. The upper channel line intersects near $75, which is an area of likely resistance. The risk/reward on this trade isn't ideal given that the profit potential is about $3 and the risk is also about $3 if a stop is placed slightly below $69.31. Therefore, if already long there is likely more upside, but if you're looking to get long being patient and waiting for a bit of a pullback is likely the best option.



United Parcel Service (NYSE:UPS) started its current trend channel in February. The lower channel line is at $86, so I'd be looking to go long anywhere between $87.50 and $86, with a stop-loss order in the $85.50 area. The upper channel line intersects near $93, so the profit target for the trade is just below this. Other than a price surges in May and July though, the price action has been fairly sedate. Therefore, the price will need to breakout above $89.25 resistance in order to potentially reach the $93 target.



SEE: Target Prices: The Key To Sound Investing

Boeing (NYSE:BA) has been in a very strong advance since March, but is currently heading toward the lower part of the rising trend channel. Channel support is at $103.25, so entry between $103.25 and $105 is looking really good. I'd put a stop near $103 and a target near the upper channel line at $113



Interpublic Group (NYSE:IPG) isn't near it's lower channel line right now, but it looks to be heading there. Toward the end of July the stock broke higher out of the trend channel and then quickly reversed, indicating selling pressure near channel resistance. Therefore, a pullback toward $15, and channel support, is possible. I'd look to get in anywhere between $15 and $15.50 with a stop-loss just below $15. The target is the upper channel line and resistance just above $17.



SEE: Trading Is Timing

The Bottom Line
Trend channels highlight rhythmic movements in price. As long as the channel holds, these movements are exploitable by buying near the lower channel line and selling near the upper line. Channels don't last forever though, so a stop-loss order should be used to control risk. Also, it is recommended that you wait for the price to begin moving higher off the lower channel line before going long. This provides a little extra assurance that the support level has held and that the price will likely start to head back toward the upper channel line.

At the time of writing, Cory Mitchell did not own shares in any of the companies mentioned in this article.

Charts courtesy of StockCharts.com.

Tuesday, April 14, 2015

Is This the Answer to Netflix's Content Problem?

Netflix (NASDAQ: NFLX  ) has a content problem. Despite spending billions each year on titles for its streaming service, the selection is far from complete.

And that's by design. Netflix is an unlimited, low-cost provider, meaning it can't offer everything while charging just $8 a month. The benefit in that approach is that it keeps the service affordable for millions of subscribers, even as an add-on to pricey cable bills.

However, under that model the company risks losing customers who search for particular titles only to find out they're not available. The fact that Netflix can deliver "similar" options just doesn't cut it with many users. And that's why the streamer needs people to browse its existing catalog, instead of searching for a given TV show or movie.

Netflix's latest attempt to get users to browse instead of search is with a service it calls "Max," which it just rolled out to Sony PlayStation 3 owners. Described as a guide that "helps you find something great to watch in a fun, conversational way," the Siri-like personality walks you through a few questions with the aim of recommending a single title you'll enjoy watching right then.

Source: Netflix.

Max takes advantage of Netflix's vast amount of user data to deliver in a quick interaction what its welcome screen does with rows of video choices. That is, Max tries to find what you're in the mood for and then tailors recommendations within that genre based on what you and others have liked in the past.

As tempting as it is to write this service off as a gimmick, I wouldn't be so quick to pan the idea. Netflix has a huge catalog of content and keeps incredibly detailed information about all of it. Anything that can make use of that data -- and get users enjoying shows beyond the most popular titles -- is good news for the company. 

We won't have to wait long to find out if the service is a hit. Assuming it delivers, Netflix plans to roll it out to other devices besides Sony's PS3, with Apple's iPad likely to be next in line. If Max does make the jump to other Netflix platforms, we'll know that the company has made at least some progress in solving one of its biggest problems.

Will Netflix own the future of television?
Even if it succeeds here, Netflix, along with other new entrants such as Amazon.com have bigger plans aimed at disrupting traditional TV networks. The Motley Fool's new free report "Who Will Own the Future of Television?" details the risks and opportunities in TV. Click here to read the full report!

Sunday, April 5, 2015

Make Money in These Growing Pharma Stocks the Easy Way

Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you'd like to add some pharmaceutical stocks to your portfolio, the SPDR S&P Pharmaceuticals ETF (NYSEMKT: XPH  ) could save you a lot of trouble. Instead of trying to figure out which companies will perform best, you can use this ETF to invest in lots of them simultaneously.

The basics
ETFs often sport lower expense ratios than their mutual fund cousins. The SPDR ETF's expense ratio -- its annual fee -- is a relatively low 0.35%.

This ETF has trounced the world markets over the past three and five years. As with most investments, of course, we can't expect outstanding performances in every quarter or year. Investors with conviction need to wait for their holdings to deliver.

Why pharmaceuticals?
A simple answer: demographics. As our global population grows and ages, and lives longer, the demand for health-care products and services seems quite likely to grow. In addition, as developing nations develop, their populations will have more money to spend on health care.

More than a handful of pharmaceutical companies had strong performances over the past year. Biotech company Santarus (NASDAQ: SNTS  ) roughly tripled in value, with an ulcerative colitis drug, Uceris, recently approved. The company posted first-quarter results that featured revenue up 73% and earnings strongly positive. Gastrointestinal disorders drug Zegerid and type 2 diabetes drug Glumetza were big performers for Santarus. Things are looking good for the company, but many think the stock is overvalued.

Pacira Pharmaceuticals (NASDAQ: PCRX  ) surged 81%, and one of its directors might be thinking that it's overvalued, too, as he sold more than $2 million worth of shares recently. (He might simply have been generating cash for some other purpose, however. While insider buying is a bullish sign, insider selling can mean many things.) Several other insiders have also sold shares, though not quite so many. The company has a pain management treatment, Exparel, which is being studied to treat additional conditions, with promising results so far. Pacira's last quarter featured growing revenue but disappointing earnings. The stock has been downgraded by Wall Street, due in part to its debt, which is coupled with net losses and negative free cash flow.

Other companies didn't do as well last year, but could see their fortunes change in the coming years. Questcor Pharmaceuticals (NASDAQ: QCOR  ) , for example, sank 13%. It's largely known for its multiple sclerosis (MS) drug, Acthar, that has sold well in the past and is being evaluated for many more indications. Questcor's management is extremely well regarded and its dividend, which yields 2.2%, was hiked by 25% earlier this year. The stock is heavily shorted, but some see it as a bargain. Questcor has bought the not-yet-approved-in-the-U.S. immune drug Synacthen from Novartis.

Zoetis (NYSE: ZTS  ) , meanwhile, is trading near the lower end of its 52-week range. It was recently spun off by Pfizer and is the world's largest animal health company and a new addition to the S&P 500. Its dividend is on the puny side at the moment, but with a low payout ratio, it has plenty of room to grow.

The big picture
Demand for pharmaceuticals isn't going away anytime soon. A well-chosen ETF can grant you instant diversification across any industry or group of companies -- and make investing in and profiting from it that much easier.

Millions of Americans have waited on the sidelines since the market meltdown in 2008 and 2009, too scared to invest and put their money at further risk. Yet those who've stayed out of the market have missed out on huge gains and put their financial futures in jeopardy. In our brand-new special report, "Your Essential Guide to Start Investing Today," The Motley Fool's personal finance experts show you why investing is so important and what you need to do to get started. Click here to get your copy today -- it's absolutely free.